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Abstract
Background: Understanding the magnitude and clinical causes of maternal and perinatal mortality are basic
requirements for positive change. Facility-based information offers a contextualized resource for clinical and
organizational quality improvement. We describe the magnitude of institutional maternal mortality, causes
of death and cause-specific case fatality rates, as well as stillbirth and pre-discharge neonatal death rates.
Methods: This paper draws on secondary data from 40 low and middle income countries that conducted
emergency obstetric and newborn care assessments over the last 10 years. We reviewed 6.5 million deliveries,
surveyed in 15,411 facilities. Most of the data were extracted from reports and aggregated with excel.
Results: Hemorrhage and hypertensive diseases contributed to about one third of institutional maternal deaths and
indirect causes contributed another third (given the overrepresentation of sub-Saharan African countries with large
proportions of indirect causes). The most lethal obstetric complication, across all regions, was ruptured uterus, followed
by sepsis in Latin America and the Caribbean and sub-Saharan Africa. Stillbirth rates exceeded pre-discharge neonatal
death rates in nearly all countries, possibly because women and their newborns were discharged soon after birth.
Conclusions: To a large extent, facility-based findings mirror what population-based systematic reviews have also
documented. As coverage of a skilled attendant at birth increases, proportionally more deaths will occur in facilities,
making improvements in record-keeping and health management information systems, especially for stillbirths and
early neonatal deaths, all the more critical.
Keywords: Cause of maternal death, Direct and indirect deaths, Cause specific case fatality rate, Stillbirth rate, Early
neonatal death rate, Perinatal mortality
Background
Post Millennium Development Goal global action agendas
such as the Sustainable Development Goals (SDGs), Every
Newborn Action Plan (ENAP) and Ending Preventable
Maternal Mortality continue to measure global progress
to reduce the maternal mortality ratio (MMR), the neo-
natal mortality rate, and now (under ENAP guidance) the
stillbirth rate [1–3]. Understanding the magnitude and
clinical causes of maternal and perinatal mortality are
basic requirements for policy setting, program design,
innovation testing, and the implementation of evidence-
based interventions. Understanding maternal and new-
born outcomes captured at health facilities presents an
opportunity for health care staff and decision-makers to
reflect on what they could do better.
High quality data on how many maternal and new-
born deaths occur and their causes are notoriously dif-
ficult to come by and global estimates come from
complex models based on multiple sources: vital regis-
tration data, confidential enquiries, large household
surveys, reproductive-age mortality studies, research
reports, surveillance data, and verbal autopsies [4–8].
Over the last few decades the Maternal Mortality
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Estimation Inter-Agency Group produced a series of ma-
ternal mortality estimates [7, 9, 10], the Global Burden of
Disease Studies contributed important systematic analyses
of trends, projections, and causes of maternal and child
mortality [6, 11, 12], while the World Health Organization
(WHO) produced two systematic analyses of the global
causes of maternal death [13, 14]. The authors of these
comprehensive systematic reviews shy away from using
routine health facility data because of inherent selection
bias. However, in the 2003–2009 WHO systematic ana-
lysis, the authors consulted health facility data when the
institutional delivery rate in that country was 50% or
greater during the period reviewed [14].
Globally, the coverage of skilled attendant at birth in-
creased from 59% in 1990 to 71% in 2015 [15]. More
countries are adopting a 100% institutional delivery policy
and institutional delivery rates are rising. This shift means
that proportionately more individuals with peripartum
and perinatal complications will access treatment, and
mortality events, when they happen, are more likely to
occur in facilities than at home. In low and middle income
countries facility-based maternal and perinatal mortality
figures do not yet substitute population-derived estimates
as they reflect only those women and newborns who suc-
ceed in accessing facility-based care. Facility-based events
are highly specific to local contextualized conditions, and
thus, are well-suited to inform local policy makers, clini-
cians and programs to target specific health system
strengthening efforts. Most importantly, they can be used
to improve service quality. As the SDGs bring a renewed
global focus on improving the quality of routine health
management information systems, through the Health
Data Collaborative and other initiatives, and as they
include the use of new technologies, data quality and
availability will increase and the cost of collecting data will
decrease.
This paper reviews data from up to 40 low and middle
income countries and describes the magnitude of insti-
tutional maternal mortality, causes of maternal death
and cause-specific case fatality rates, as well as institu-
tional stillbirth and early or pre-discharge neonatal death
rates, in most cases, at the national level. This analysis
draws on reports produced over the last decade.
Methods
This secondary data analysis is based on a review of cross-
sectional health facility surveys known as emergency ob-
stetric and newborn care (EmONC) assessments, which
focus on routine intrapartum care for women and their
newborns as well as more complicated births. These as-
sessments have been driven by the United Nations Fund
for Population (UNFPA), the United Nations Children’s
Fund (UNICEF), the WHO, and the Averting Maternal
Death and Disability (AMDD) program at Columbia
University. The methods have been described elsewhere,
but a summary follows [16, 17].
Sampling
Most EmONC assessments were national in scope and
targeted facilities providing childbirth services. As a rule,
all hospitals were selected, and if a “census” of childbirth
sites was not possible, hospitals were supplemented by
either a random sample of mid-level facilities (health
centers, clinics), or a “restricted census” of higher volume
mid-level facilities that attended more than a specified
number of monthly deliveries. Usually, both private and
public sector facilities were included. Table 1 shows the
number of hospitals and other facilities surveyed in each
country and the population size covered by the facilities
visited.
Primary data collection instruments
In each country, a core team adapted a set of standard-
ized instruments that covered the availability and status
of infrastructure, human resources, drugs, equipment,
and supplies, and service statistics, in addition to a pro-
vider interview and chart reviews [18]. Most relevant to
this paper was the 12-month retrospective summary of
service statistics that included the number of deliveries,
women experiencing obstetric and non-obstetric com-
plications by type of complication, maternal deaths by
cause, and birth outcomes. Data collectors extracted
data from logbooks in labor and delivery wards, mater-
nity wards, operating theatres, and newborn care
units in each facility. When any doubt or clarification
was required, data collectors turned to the staff on
duty.
Definitions of causes of maternal death were informed
by the international statistical classification of diseases
and related health problems, 10th edition (ICD-10) and
its application to deaths during pregnancy, childbirth
and the puerperium (ICD-MM). Obstetric complications
were elaborated upon to distinguish between antepartum
and postpartum hemorrhage and retained placenta. Pro-
longed and obstructed labor were included, sometimes
joined as one category. Ruptured uterus and ectopic preg-
nancy along with postpartum sepsis, severe pre-eclampsia
and eclampsia were the final “major direct complications”
listed on the instrument. Indirect complications included
malaria, HIV/AIDS, severe anemia, and less commonly,
hepatitis and diabetes. In each case, the form included a
category for “other” direct complications and “other” in-
direct complications. Causes of death mirrored the listing
of complications. Finally, space permitted the reporting of
unspecified/unknown causes of maternal death. For the
12-month summary of maternal deaths, the data collec-
tors were guided by the primary sources they located on
the wards or with the staff. Where maternal death audits
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or reviews took place, those records were also accessed,
but generally no subsequent recoding was performed.
The 12-month retrospective compilation of service
statistics was also designed to test the intrapartum and
early neonatal death rate as an indicator of intrapartum
care quality [19]. Data extraction from maternity or
delivery registers captured the number of antepartum
(macerated) and intrapartum (fresh) stillbirths, defined
by 28 weeks of gestation or more. Intrapartum stillbirths
and live births were divided between those weighing
above and below 2500 g. Early neonatal deaths were de-
fined as those occurring before discharge or within the
first 24 h, whichever came first. Countries varied widely
as to level of detail captured, and thus, categories were
added for unspecified stillbirths and birth weights when
the timing of death or birth weight was not recorded,
and for live births and early neonatal deaths when birth
weight was not recorded.
These categories for maternal and newborn outcomes
were standardized across countries. Data collectors were
trained to use a manual with the same definitions for
each obstetric complication, type of stillbirth and early
neonatal death.
Secondary analysis
EmONC assessment final reports were the source of
most of the data compiled in this paper; we had access
to primary data in nine countries, but only in two or
three situations did we access those data. Because
reporting was largely driven by country interests, not
all reports contained the same information nor was it
presented in a standardized fashion. Consequently, the
number of countries in each table differs. For example,
some countries did not report the major obstetric com-
plications by type of complication, making it impossible
to calculate cause specific case fatality rates. One report
candidly reported that the number of maternal deaths
was grossly underreported and was not included. Other
countries presented the intrapartum and pre-discharge
neonatal death rate as recommended, restricting the
numerator and denominator to babies weighing 2500 g
or more, but they failed to report all stillbirths, nor did
they report the number for which birth weight or stillbirth
timing was unspecified; these data were not included in
the paper. A small number of countries reported only dir-
ect maternal deaths, omitting the number of unspecified/
unknown maternal deaths or indirect deaths; these reports
were retained. Some countries distinguished between
antepartum hemorrhage and postpartum hemorrhage,
while others reported the two together.
About 10 of the 40 countries had conducted more
than one EmONC assessment. In all cases, we extracted
information from the most recent report except for
Ethiopia, whose final report for their most recent assess-
ment was not yet available.
Based on numbers drawn from the reports, we cal-
culated the percentage of deliveries with obstetric
complications and the institutional maternal mortality
ratio, using 100,000 deliveries rather than live births
since some countries only counted deliveries. We also
calculated any regional aggregations, newborn mortal-
ity rates, and the ratio of stillbirths to early neonatal
deaths. The case fatality rate was calculated by divid-
ing the number of maternal deaths due to a specific
complication by the number of complications treated.
The stillbirth rate was estimated by dividing the total
number of stillbirths by all deliveries (multiplied by
1000); the pre-discharge neonatal mortality rate was
similar but we removed the deliveries resulting in a
stillbirth from the denominator.
Data collection and management
Ministries of Health provided oversight to all EmONC
assessments and were usually supported by a technical
steering committee. Public or private research institu-
tions, universities, or central statistical offices were the
most common implementing bodies for the assess-
ments. Data collection teams usually consisted of four
data collectors, generally having a health background.
Data collectors participated in a weeklong training that
included a review of each questionnaire, role plays, and
exercises to familiarize themselves with the question-
naires and the data collectors’ manual. Each training in-
cluded a one-day field activity in local hospitals and
health centers where teams completed the question-
naires under supervision. Generally, quality assurance
teams closely monitored the first week or two of field
activities. Teams usually required one to two days to
complete a hospital and half a day to complete a health
center.
Data collection was paper-based for all countries but
one, and data entry performed with CSPro. Report ana-
lyses were produced with statistical software such as
STATA, SPSS or sometimes excel. When mid-level fa-
cilities were sampled, the data were weighted based on
selection probability. Weighting is required to account
for the non-uniform selection probabilities that would
affect how data from selected facilities represent all fa-
cilities, including those not selected.
Technical support was provided by consultants to the
AMDD program. Countries varied by the intensity of
support – from no direct AMDD support (Ecuador,
Panama, Cote d’Ivoire, Eritrea), to minimal remote support
(Mongolia, Cambodia, Afghanistan), to most countries with
more intensive support. UNFPA and UNICEF were the pre-
dominant supporters for EmONC assessments but bilateral
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partners and foundations also played important roles de-
pending on the country.
Ethical concerns
Names of women or other identifying information were
never included in the primary data collection. Countries
followed the guidance of their ministries of health and
when required, approval of the protocols and data collec-
tion instruments from local institutional review boards
was obtained. No additional approval was sought for this
paper since the primary source of the data were reports in
the public domain.
Results
Up to 40 country reports (including Zanzibar) provided
the number of maternal deaths that took place within
health care institutions, 31 from sub-Saharan Africa, and
the remaining nine from Latin America and the Caribbean
and Asia (Table 1). The scope of EmONC assessments
ranged from all nine hospitals in the province of Azuay,
Ecuador to 1626 facilities in Burkina Faso, inclusive of
all facilities with at least one delivery in the past
12 months. The total number of facilities (15,411) regis-
tered 6.5 million deliveries and 17,314 maternal deaths.
To contextualize the number of institutional maternal
deaths and associated MMR, we included the institu-
tional delivery rate and the percentage of institutional
deliveries with a major direct obstetric complication.
Both indicators were derived from EmONC assessment
data. The final column includes the 2015 population-
based MMR estimated by the Maternal Mortality Estima-
tion Inter-Agency Group [7], also included for context,
although most assessments occurred before 2015. Institu-
tional delivery rates ranged from 7% in Ethiopia in 2008–9
to 113% in Mongolia (likely explained by a non-standard
sampling strategy of 21 hospitals and their catchment
areas). The next highest institutional delivery rate was
88% in São Tomé & Príncipe. Institutional MMRs ranged
from 2130 maternal deaths per 100,000 deliveries in Chad
to 32 in Mongolia.
Countries with relatively low coverage of institutional
deliveries such as Haiti, Niger, Sierra Leone, Ethiopia,
South Sudan, Angola, and Chad tended to have high in-
stitutional MMRs, suggesting that a disproportionate
number of women delivering in facilities experienced
serious complications. To some extent, the percentage
of deliveries with major obstetric complications sup-
ports this pattern where high percentages were found
in countries with high institutional MMRs. However,
countries such as the Democratic Republic of Congo or
Afghanistan also exhibited relatively low institutional
delivery rates, 10% or more of deliveries with complica-
tions, and had institutional MMRs of less than 200,
making it difficult to discern any robust pattern. A high
percentage of complicated deliveries could also reflect
the type of facility surveyed, e.g. Ecuador (30%) and
Mongolia (28%), where only hospitals were assessed.
Causes of institutional maternal deaths and cause specific
case fatality rates
Figure 1 shows the distribution of all reported causes
of maternal death for 38 countries. In 20 countries,
hemorrhage and hypertensive diseases (severe pre-
eclampsia/eclampsia) approached or exceeded 40% of
maternal deaths. Similarly, 10 countries reported simi-
lar levels of indirect causes of maternal death.
Only 33 countries reported the number of women
with major obstetric complications by type of complica-
tion, found in the regional summaries of Table 2 (upper
panel). In the Latin America and Caribbean region,
hypertensive disorders ranked first (41% of direct mater-
nal deaths), while hemorrhage ranked first in sub-
Saharan Africa (33%) and Asia (42%). The lower panel
shows that in sub-Saharan Africa 61% of maternal deaths
were attributable to direct causes, 35% to indirect causes
and 4% were unspecified or unknown, while Latin
America and the Caribbean and Asian regions were
weighted towards a larger proportion of direct causes of
death.
Ruptured uterus had the highest cause-specific case
fatality rate in each region, ranging from 8.9% in sub-
Saharan Africa to 2.5% in the Latin America and
Caribbean region. In other words, for every 100 women
with a ruptured uterus in sub-Saharan Africa, 9 will die.
The second highest specific cause of death was postpar-
tum sepsis in sub-Saharan Africa (5.7%) and in Latin
America and the Caribbean (1.1%), while in Asia,
hypertensive diseases and hemorrhage tied for second
(0.9%).
Seventeen sub-Saharan African countries reported
the number of indirect complications and deaths due to
malaria in pregnancy, HIV/AIDS, severe anemia and
other indirect causes of death. A few countries reported
sickle cell anemia, hepatitis and diabetes, but most
countries placed these women in the category of
“other” indirect complications; 68% of indirect compli-
cations were malaria-related, 13% to HIV/AIDS, 7% to
anemia, and 12% to “other indirect” complications. Less
than 1% of indirect complications reported were cases
of sickle cell anemia, hepatitis or diabetes, but more
than a third of pregnant or recently delivered women
with hepatitis or diabetes died before discharge (under-
reporting of survivors was likely). The case fatality rate
for anemia was 2.3%, 1.0% for HIV/AIDS, 0.5% for mal-
aria, and 1.6% for “other” indirect complications (data
not shown).
Figure 2 depicts the cause-specific case fatality rates for
direct obstetric complications, organized by countries
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within regions. Hashed bars indicate a case fatality
rate based on small numbers. Angola, Chad, Congo
Brazzaville, Guinea, Mauritania, Senegal, and South
Sudan experienced high rates (≥4%) across three or
more complications.
Institutional stillbirth and pre-discharge early neonatal
mortality rates
Twenty-three countries calculated stillbirth and pre-
discharge early neonatal death rates, nine of which did not
distinguish between antepartum and intrapartum still-
births, while two countries calculated only a pre-discharge
perinatal mortality rate (Table 3 and Fig. 3). Stillbirth rates
ranged from 5.8 per 1000 deliveries in Mongolia, to 116.5
in Madagascar. Pre-discharge neonatal death rates were
often much smaller than the stillbirth rates except for
Mongolia. Early neonatal death rates ranged from 1.8 in
Guinea to 21 in Bangladesh. The ratio of stillbirths to early
neonatal deaths varied widely across countries, ranging
from the outlier ratios of 26 and 25 stillbirths to 1 pre-
discharge neonatal death in Madagascar and Guinea to 0.7
to 1 in Mongolia. Mongolia had the lowest institutional and
population-based MMR and the lowest stillbirth rate, but
its pre-discharge early neonatal death rate was similar to
that of many countries, and begs for an explanation – a
question of sampling or quality of newborn care?
Discussion
This institutional assessment compiles data from many
countries where every country set out with similar
Fig. 1 Distribution of causes of maternal death (38 countries). São Tomé & Príncipe, Sierra Leone, Rwanda and Ecuador reported only direct
causes of maternal death; HEM=hemmorrhage; PEE=pre-eclampsia, eclampsia; OBSTR=obstructed/prolonged labor; RU=ruptured uterus;
SEP=sepsis; AB=abortion; EC=ectopic pregnancy; OTH DIR=other direct causes of death; IND=indirect causes of death; UNSPEC=unspecified/
unknown cause of death
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objectives, used a similar methodology and data collec-
tion instrument, and had common indicators. By design,
each assessment captured a complete recording of all
maternal deaths by cause and common perinatal out-
comes. This is a strength that other multi-country stud-
ies have not shared. In this overview, we gathered
service statistics from more than 15,400 health care fa-
cilities that mirror findings from more complex model-
ing exercises, regardless of differences in methodology
and reference populations.
We saw hypertensive diseases as the predominant cause
of institutional maternal death in the Latin America and
Caribbean region and hemorrhage highlighted in Asian
countries, despite the small number of surveys in each of
those regions. Meanwhile, hemorrhage was the predomin-
ant cause of institutional maternal deaths in sub-Saharan
African countries, a region also distinguished by its large
proportion of indirect maternal deaths.
In Table 4 below we compare the overall distribution
of institutional causes of 14,785 deaths from 26 sub-
Saharan African countries with the population-based
distribution found in the WHO 2003–2009 systematic
review (in both cases, unknown causes of death were ex-
cluded). Cases of ruptured uterus and obstructed labor
were included in “other direct causes” for the EmONC
Assessments while these cases were likely assigned to
hemorrhage or sepsis in the WHO study [14]. The de-
gree of similitude in the distribution of causes is both
validating and reassuring but may also point to possible
data quality issues and/or differences between all deaths
versus just those occurring in facilities.
The larger proportion of indirect causes found in this
paper is noteworthy but it also may be underreported
especially where comorbidities were common. During
the training, data collectors were instructed to classify a
maternal death as direct if there was evidence of both
direct and indirect causes. For programmatic purposes,
indirect causes of maternal mortality require a greater
focus of attention, not just for purposes of reporting but
also for health service delivery organization to intervene
early to prevent these deaths.
We also observed that institutional stillbirth rates
tended to be substantially higher than early neonatal death
rates, and that countries with high institutional stillbirth
rates also tended to exhibit high institutional MMRs.
According to other studies, we might have expected the
ratio of stillbirths to early neonatal deaths to be approxi-
mately 1.3 to 1, but these institutional data suggest a lower
ratio, i.e., more stillbirths than expected [20, 21]. Unfortu-
nately, given the uneven reporting of whether the stillbirth
Fig. 2 Cause-specific case fatality rates by region and country (33 countries). Hashed bars represent rates based on very small numbers;
HEM=hemmorrhage; OBL=obstructed/prolonged labor; RU=ruptured uterus; SEP=sepsis; PEE=pre-eclampsia, eclampsia; AB=abortion; ECT=ectopic
pregnancy; LAC=Latin America & the Caribbean; Maurit=Mauritania; Mozam=Mozambique; Ecua=Ecuador; Guya=Guyana; Nica=Nicaragua;
Panam=Panama; Afghan=Afghanistan; Bangla=Bangladesh; Camb=Cambodia; Mongol=Mongolia; STP=São Tomé e Príncipe
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was macerated or intrapartum, the often-cited ratio of 1
intrapartum stillbirth to 3 macerated stillbirths could not
be assessed [22].
The 2030 ENAP target for the stillbirth rate is 12/1000
total births and the target neonatal death rate is the
same, but among live births. At this time, most countries
in this overview are far from reaching the stillbirth target
and many countries would fail to reach the neonatal tar-
get of 12, although this is more difficult to ascertain
given the censoring of data since so many women and
their newborns are discharged within 12 h of delivery. A
recent six-country study of early neonatal mortality
showed that neonatal deaths in the first six and 24 h ac-
count for one-third and 46%, respectively, of all neonatal
deaths [23]. Therefore, a doubling or tripling of the early
neonatal deaths observed in this overview might provide
a rough estimate of the actual neonatal death rate. But
like the MMR, it is unclear whether institutional rates
and ratios are likely to be higher or lower than the
population-based rates. Nevertheless, high stillbirth rates
observed in the EmONC assessments give pause; the
global stillbirth rate for 2015 was 18.4 per 1000 births,
while the rate for sub-Saharan Africa was 28.7 [4]. Ac-
cording to the authors of recent trend data for stillbirth
rates, when compared to high quality vital registration
data, facility data tend to overestimate the stillbirth rate
due to selection bias [4, 5].
Despite evidence for reductions in maternal and peri-
natal mortality over the last two decades, this multi-
country overview leads to recommendations for clinical
practice and policy if we are to move towards the goal of
ending preventable maternal and newborn deaths. From
Table 3 Institutional stillbirth and pre-discharge early neonatal mortality rates (23 countries)
Region, country and
year of data collection
Institu-tional
deliveries
Ante-partum
SBs
Intra-partum
SBs
Unspe-cified
SBs
Total
SBs
SB rate per
1000 deliveries
pNDs pND rate per
1000 live births
SB:pND
ratio
LAC
Guyana 2010 12,803 70 67 89 226 17.7 65 5.2 3.5
Nicaragua 2006 94,136 NR NR NR 1210 12.9 889 9.6 1.4
Western Africa
Gambia 2012 51,518 1023 944 66 2033 39.5 433 8.8 4.7
Ghana 2010 434,508 3989 4685 1223 9897 22.8 2201 5.2 4.5
Guinea 2011 141,724 1944 1457 3639 6040 42.6 242 1.8 25.0
Niger 2010 152,415 1171 4105 1072 6348 41.6 545 3.7 11.6
Senegal 2013 237,494 3761 3345 2078 9184 38.7 1439 6.3 6.4
Togo 2012 133,119 974 1728 1150 3852 28.9 634 4.9 6.1
Eastern Africa
Eritrea 2008 25,000 NR NR NR 933 37.3 185 7.7 5.0
Ethiopia 2008–9 174,561 NR NR NR 7366 42.2 522 3.1 14.1
Madagascar 2009 118,774 NR NR NR 13,832 116.5 527 5.0 26.2
Malawi 2014 476,272 3632 4403 NR 8035 16.9 5028 10.7 1.6
Mozambique 2012a 647,944 828 3440 8200 12,468 19.2 1380 2.2 9.0
Rwanda 2007a 207,738 17,456 5618 NR 23,074 11.1 9432 5.1 2.4
South Sudan 2013 52,842 208 541 373 1122 21.2 948 18.3 1.2
Zambia 2014–15 475,646 NR NR NR 11,233 23.6 1980 4.3 5.7
Central Africa
Chad 2011 49,202 274 814 NR 2155 43.8 239 5.1 9.0
Congo 2012 85,038 657 856 219 1732 20.4 264 3.2 6.6
Dem Rep Congo 2011 156,546 NR NR NR 5949 38.0 1271 8.4 4.7
Asia
Afghanistan 2009 192,627 NR NR NR 4177 21.7 1422 7.5 2.9
Bangladesh 2012 253,728 NR NR NR 8119 32.0 5158 21.0 1.6
Cambodia 2014 119,931 92 715 NR 807 6.7 479 4.0 1.7
Mongolia 2009 30,131 NR NR NR 175 5.8 242 8.1 0.7
NR not reported, SB stillbirth, pND pre-discharge early neonatal death, dying before discharge or within the first 24 h, whichever came first
aMozambique and Rwanda adjusted to reflect 12 months of information
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the clinical perspective, although fewer in absolute num-
bers than hemorrhage or hypertensive disorders, uterine
rupture and maternal sepsis were the most lethal compli-
cations. The literature consistently shows the elevated risk
of mortality from ruptured uterus [24–27]. High case
fatality rates for uterine rupture suggest poor diagnostic
skills, inadequate patient monitoring after admission and
delays in appropriate treatment [28], or perhaps inappro-
priate or overuse of augmentation or induction. Several
studies point to high rates of rupture after admission
[25, 29]. Ruptured uterus is also an indication that
women with obstructed labor or at risk of rupture, e.g.
having a previous uterine scar, still experience difficul-
ties in accessing surgical care in a timely manner.
Considerable international investment has focused on
reducing deaths due to hemorrhage and hypertensive
disorders, given how many deaths are attributable to
these complications. Both have well-known pharmaco-
logical solutions as well as effective preventative mea-
sures with active management of the third stage of
Fig. 3 Institutional stillbirth and pre-discharge neonatal death (pND) rates (25 countries)
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labor and the potential to detect high blood pressure
and proteinuria during antenatal care. Ruptured uterus
might be viewed as requiring more complex multi-
sectoral fixes – improved road networks, better com-
munication and transportation options, as well as the
human resources who can and will monitor the pro-
gression of labor, follow protocol, and perform cesarean
delivery. Sepsis may require more of a professional cul-
ture change towards infection prevention, more access-
ible water, sanitation and hygiene infrastructure as well
as antenatal screening.
To optimize the investment of an EmONC assessment,
it should be followed by multilevel planning and imple-
mentation phases. In 2016, only six of the countries
mentioned in this publication have set up such processes
that include maternal and newborn care monitoring in
EmONC facilities (Burkina Faso, Cambodia, Haiti,
Madagascar, Niger and Togo). However, this number is
likely to increase significantly in 2017. The production,
analysis and utilization of data by providers with the
support of coaches also contribute to improve quality of
care.
Limitations
Without access to the original data, we could not
standardize reporting nor could we stratify by level of fa-
cility or management authority, which would have
allowed a deeper understanding of which deaths oc-
curred where and how many. There may also have been
bias in how causes of death were ascertained across
countries although training guidelines were the same
across most countries. It is possible that some countries
were more comfortable than others using ICD-MM. Go-
ing forward, EmONC assessments should better align
the cause of death categories with ICD-MM, thus mak-
ing these data more attractive as an additional source for
global estimates.
Systematic documentation of stillbirths is at an early
stage in many low and middle income countries and
the differentiation between antepartum and intrapar-
tum stillbirths is not yet standard practice across or
within countries. Like maternal deaths, stillbirth rates
and early neonatal death rates are susceptible to errors
of omission and misclassification [30]. Especially critical
may be widespread misclassification of early neonatal
deaths as intrapartum stillbirths due to lack of diagnos-
tic skill, environmental pressure or convenience. Coun-
tries such as Madagascar, Guinea and Ethiopia that
exhibited an extreme ratio of stillbirths to early neo-
natal deaths should investigate these rates to under-
stand possible contributory clinical and reporting
practices. Caregivers need access to simple equipment
to measure the presence of fetal heart beats on admis-
sion, training to make accurate assessments and the
paper or electronic tools that encourage reporting
whether the fetal death was antepartum or intrapartum
[31]. As long as large numbers of stillbirths and birth
weights remain unspecified, the use of the intrapartum
and early neonatal death rate as an indicator for quality
of intrapartum care will be compromised or relegated
to the status of a special study.
The recording of maternal deaths is likely to be in-
complete given the primary sources of the statistics –
routine paper-based logbooks – the extended coverage
of 12 months, and for unintentional and intentional
reasons. Obstetric complications are also likely to be
undercounted as they are rarely collected by routine
health management information systems. Specific case
fatality rates suggest inconsistent reporting and re-
cording across facilities and countries. For example,
the case fatality rate of 1% for HIV in sub-Saharan
Africa was surprisingly low as were the case fatality
rates of 0% for hemorrhage in Ecuador, and 0% for
obstructed labor in Ghana, Togo and the Gambia.
Nevertheless, by supporting the EmONC assessments
we have learned that registers and logbooks tend to be
more complete than facility reports of aggregated data.
We also observed that where maternal death surveil-
lance and response (MDSR) initiatives were well
entrenched, the quality of the maternal death data in
the EmONC assessments appeared to be of higher
quality than where MDSR efforts were in their early
stages. As countries adopt Making Every Baby Count:
Audit and Review of Stillbirths and Neonatal Deaths,
routine data on newborn outcomes are likely to im-
prove in quality as will our understanding of why
deaths occur and how to intervene.
Conclusions
As skilled delivery coverage increases and maternal mor-
tality declines, women who die in facilities may no lon-
ger represent the tip of an iceberg, but most maternal
deaths. With appropriate reflection, institutional still-
birth and early neonatal death rates, causes of maternal
Table 4 Comparison of causes of maternal mortality in sub-
Saharan countries by different sources
For sub-Saharan
African countries
EmONC Assessments
(institution-based)
WHO 2003–2009 Review
(population-based)
Hemorrhage 21.0% 24.5%
Abortion + ectopic
pregnancy
7.2% 9.6%
Sepsis 6.0% 10.3%
Hypertensive diseases 10.5% 16.0%
Other direct causes 17.8% 11.1%
Indirect causes 37.5% 28.6%
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death and case fatality rates can guide management on
how to improve health workers’ capacity to meet the de-
mand for emergency care, including record-keeping, and
identify hotspots of where and what is needed to reduce
delays in seeking, reaching and receiving care. Facility-
level data will become all the more important and thus
efforts to improve data quality are crucial.
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